推荐产品
质量水平
方案
99%
折射率
n20/D 1.45 (lit.)
沸点
237 °C/733 mmHg (lit.)
密度
1.188 g/mL at 25 °C (lit.)
官能团
carbonate
储存温度
2-8°C
SMILES字符串
C=CC1COC(=O)O1
InChI
1S/C5H6O3/c1-2-4-3-7-5(6)8-4/h2,4H,1,3H2
InChI key
BJWMSGRKJIOCNR-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
4-乙烯基-1,3-二氧杂环戊烷-2-酮 (VEC) 是一种环状碳酸酯,可由丙烯醛与硫叶立德和 CO 2 反应合成 。在 2-丙醇存在下,钌催化的 VEC 转移氢化 (TH) 形成 1,2-丁二醇。吲哚和吲哚在铑 (III) 催化剂存在下与 VEC 发生选择性 C-H 烯丙基化反应。
应用
4-乙烯基-1,3-二氧杂环戊烷-2-酮可用于制备 2-芳基苯并 [d] 噻唑骨架。
可用于合成以下多功能环碳酸盐:
可用于合成以下多功能环碳酸盐:
- 4,4′-((己烷-1,6-二基双(磺基二基))双-(乙烷-2,1-二基))双(1,3-二氧杂环戊烷-2-酮)(Bis-CC)
- 2-乙基-2-((3-((2-(2-(2-氧代-1,3-二氧杂环戊烷-4-基)-乙基)硫代)丙酰基)氧)甲基)丙烷-1,3-二基双(3-((2-(2-(2-氧代-1,3-二氧杂环戊烷-4-基)乙基)硫代)丙酸酯)(Tris-CC)
- 2,2-双((3-((2-(2-(2-氧代-1,3-二氧杂环戊烷-4-基)乙基)-硫代)丙酰基)氧)甲基)丙烷-1,3-二基双(3-((2-(2-(2-氧代-1,3-二氧杂环戊烷-4-基)乙基)硫代)丙酸酯)(四 CC)
用于合成功能性聚合物。
警示用语:
Danger
危险声明
危险分类
Acute Tox. 3 Oral
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 1
闪点(°F)
206.4 °F - closed cup
闪点(°C)
96.9 °C - closed cup
个人防护装备
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Tunable poly (hydroxyl urethane) from CO2-Based intermediates using thiol-ene chemistry.
Tang CN, et al.
Journal of Polymer Science Part A: Polymer Chemistry, 49(9, 2024-2032 (2011)
Yu Nan Jiang et al.
Biology open, 7(6) (2018-05-03)
Co-culture of bone marrow stromal cells (BMSCs) and vascular endothelial cells (VECs) is a promising strategy for better osteogenesis and pre-vascularization in bone tissue engineering. Recent reports have shown that mechanical stretching further promotes osteogenesis in BMSC/VEC co-culture systems, but
Rhodium-catalyzed mild and selective C-H allylation of indolines and indoles with 4-vinyl-1,3-dioxolan-2-one: facile access to indolic scaffolds with an allylic alcohol moiety.
Sharma S, et al.
Tetrahedron, 71(16), 2435-2441 (2015)
John R Brannon et al.
Nature communications, 11(1), 2803-2803 (2020-06-06)
Host-associated reservoirs account for the majority of recurrent and oftentimes recalcitrant infections. Previous studies established that uropathogenic E. coli - the primary cause of urinary tract infections (UTIs) - can adhere to vaginal epithelial cells preceding UTI. Here, we demonstrate
James J Beaudoin et al.
Drug metabolism and disposition: the biological fate of chemicals, 47(2), 155-163 (2018-12-07)
Tolvaptan, a vasopressin V2-receptor antagonist, has demonstrated efficacy in slowing kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD). In the pivotal clinical trial, the incidence of elevated liver enzymes was higher in patients receiving tolvaptan compared
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门